VMAR:NASDAQVision Marine Technologies Inc. Analysis
Data as of 2026-06-22 - not real-time
$2.97
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Vision Marine Technologies is trading well below its short‑term moving averages, with price under the 20‑day and 50‑day SMA, indicating a bearish price action. The RSI is in the low‑20s, suggesting the stock is oversold, while the MACD shows a modest bullish histogram, hinting at a potential short‑term reversal. Fundamentally, the company reports soaring revenue growth but negative margins, a massive debt load relative to equity, and negligible cash generation, creating a stark contrast between top‑line momentum and bottom‑line weakness. Recent filings for a reverse‑stock split and a new electric outboard patent underscore ongoing corporate actions aimed at restructuring and technology development, yet the extreme volatility and near‑zero market cap keep the risk profile elevated.
Given the blend of technical oversold signals, speculative growth prospects in electric marine propulsion, and a distressed balance sheet, the stock remains a high‑risk play that may appeal only to investors seeking deep‑value or turnaround opportunities.
Given the blend of technical oversold signals, speculative growth prospects in electric marine propulsion, and a distressed balance sheet, the stock remains a high‑risk play that may appeal only to investors seeking deep‑value or turnaround opportunities.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- RSI indicates oversold conditions
- Price below key moving averages
- Weak cash flow and high debt
Medium Term
1–3 yearsNeutral
Model confidence: 4/10
Key Factors
- Revenue growth remains strong
- Continued negative profitability
- Potential upside from new electric outboard patent
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Emerging market for electric marine vessels
- Significant upside if balance sheet can be restructured
- Low price relative to book value
Key Metrics & Analysis
Financial Health
Revenue Growth19273.00%
Profit Margin-54.94%
P/E Ratio-0.0
ROE-185.95%
ROA-18.05%
Debt/Equity309.23
P/B Ratio0.1
Op. Cash Flow$-242412
Free Cash Flow$-26597848
Technical Analysis
TrendBearish
RSI27.4
Support$2.11
Resistance$7.34
MA 20$4.46
MA 50$9.21
MA 200$212.09
MACDBullish
VolumeIncreasing
Fear & Greed Index90.14
Valuation
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.59
Volatility155.94%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.